400
Participants
Start Date
December 31, 2016
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
There is no intervention
There are no interventions
RECRUITING
Mount Sinai Hospital, New York
ACTIVE_NOT_RECRUITING
Columbia University, New York
ACTIVE_NOT_RECRUITING
Albert Einstein College of Medicine, The Bronx
RECRUITING
Lehigh Valley Health Network, Allentown
RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
University of Virginia, Charlottesville
RECRUITING
University of North Carolina, Chapel Hill
RECRUITING
Ohio State University, Columbus
ACTIVE_NOT_RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Northwestern University, Chicago
RECRUITING
University of Arkansas for Medical Sciences, Little Rock
RECRUITING
University of Texas Health Science Center at San Antonio, San Antonio
RECRUITING
University of New Mexico, Albuquerque
ACTIVE_NOT_RECRUITING
University of Southern California, Los Angeles
RECRUITING
Oregon Health & Science University, Portland
RECRUITING
Stanford University, Palo Alto
RECRUITING
Yale University, New Haven
MOUNT SINAI HOSPITAL
OTHER
University of North Carolina
OTHER
Northwestern University
OTHER
University of New Mexico
OTHER
Stanford University
OTHER
The University of Texas Health Science Center at San Antonio
OTHER
Ohio State University
OTHER
Yale University
OTHER
Albert Einstein College of Medicine
OTHER
Oregon Health and Science University
OTHER
Lehigh Valley Health Network
OTHER
University of Arkansas
OTHER
University of Southern California
OTHER
University of Virginia
OTHER
Regeneron Pharmaceuticals
INDUSTRY
Boehringer Ingelheim
INDUSTRY
GlaxoSmithKline
INDUSTRY
Gilead Sciences
INDUSTRY
Juvenile Diabetes Research Foundation
OTHER
Novo Nordisk A/S
INDUSTRY
University of Pennsylvania
OTHER